Cargando…
Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) is considered to be a devastating pathogen worldwide, affecting millions of people globally. Several drugs targeting distinct pathways are utilized for the treatment of tuberculosis. Despite the monumental efforts being directed at the discovery of drugs for Mtb, the...
Autores principales: | Yelamanchi, Soujanya D., Mishra, Archita, Behra, Santosh Kumar, Karthikkeyan, Gayathree, Keshava Prasad, Thottethodi Subrahmanya, Surolia, Avadhesha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228056/ https://www.ncbi.nlm.nih.gov/pubmed/35736426 http://dx.doi.org/10.3390/metabo12060493 |
Ejemplares similares
-
Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022) -
Data on dose-dependent cytotoxicity of rotenone and neuroprotection conferred by Yashtimadhu (Glycyrrhiza glabra L.) in an in vitro Parkinson's disease model
por: Karthikkeyan, Gayathree, et al.
Publicado: (2021) -
Identification of Molecular Network Associated with
Neuroprotective Effects of Yashtimadhu (Glycyrrhiza
glabra L.) by Quantitative Proteomics of Rotenone-Induced
Parkinson’s Disease Model
por: Karthikkeyan, Gayathree, et al.
Publicado: (2020) -
From LC-MS/MS metabolomics profiling of Kanchanara Guggulu to molecular docking and dynamics simulation of quercetin pentaacetate with aldose reductase
por: Behera, Santosh Kumar, et al.
Publicado: (2021) -
An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a novel combinatorial therapy
por: Mishra, Archita, et al.
Publicado: (2018)